Oberweis Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325K Hold
1,450
0.01% 166
2025
Q4
$349K Hold
1,450
0.01% 169
2025
Q3
$397K Hold
1,450
0.02% 172
2025
Q2
$374K Hold
1,450
0.02% 175
2025
Q1
$325K Hold
1,450
0.02% 182
2024
Q4
$332K Hold
1,450
0.02% 188
2024
Q3
$354K Hold
1,450
0.02% 195
2024
Q2
$278K Hold
1,450
0.02% 189
2024
Q1
$287K Hold
1,450
0.02% 186
2023
Q4
$249K Hold
1,450
0.02% 187
2023
Q3
$214K Hold
1,450
0.02% 189
2023
Q2
$317K Hold
1,450
0.04% 170
2023
Q1
$318K Hold
1,450
0.05% 160
2022
Q4
$302K Hold
1,450
0.06% 156
2022
Q3
$317K Hold
1,450
0.07% 157
2022
Q2
$304K Hold
1,450
0.08% 143
2022
Q1
$352K Hold
1,450
0.07% 128
2021
Q4
$378K Hold
1,450
0.07% 119
2021
Q3
$382K Hold
1,450
0.08% 117
2021
Q2
$357K Hold
1,450
0.08% 116
2021
Q1
$281K Hold
1,450
0.06% 135
2020
Q4
$308K Hold
1,450
0.08% 111
2020
Q3
$249K Hold
1,450
0.08% 106
2020
Q2
$278K Sell
1,450
-200
-12% -$32.7K 0.11% 108
2020
Q1
$243K Hold
1,650
0.13% 137
2019
Q4
$256K Hold
1,650
0.09% 176
2019
Q3
$223K Hold
1,650
0.05% 184
2019
Q2
$201K Buy
+1,650
New +$183K 0.04% 190

Other funds holding RMD

Oberweis Asset Management's RMD Position: Q1 2026 in Review

Oberweis Asset Management held its ResMed (RMD) position steady in Q1 2026 at 1,450 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #166.

Oberweis Asset Management first reported a position in RMD in Q2 2019 and has held it in 28 quarters since. The position peaked at $397K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Oberweis Asset Management held 1,450 shares of ResMed worth $325K as of Q1 2026.
  • Oberweis Asset Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.01% of Oberweis Asset Management's portfolio in Q1 2026, its #166 holding.
  • Oberweis Asset Management first reported a position in ResMed in Q2 2019 and has held it in 28 quarters since.
  • Oberweis Asset Management's ResMed position peaked at $397K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.